| Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine G Carli, I Nichele, M Ruggeri, S Barra, A Tosetto Internal and emergency medicine 16, 803-804, 2021 | 182 | 2021 |
| Risk of exposure to bloodborne infection for Italian healthcare workers, by job category and work area V Puro, G De Carli, N Petrosillo, G Ippolito Infection Control & Hospital Epidemiology 22 (4), 206-210, 2001 | 176 | 2001 |
| Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial T Barbui, AM Vannucchi, V De Stefano, A Masciulli, A Carobbio, A Ferrari, ... The Lancet Haematology 8 (3), e175-e184, 2021 | 111 | 2021 |
| A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia B Rocca, A Tosetto, S Betti, D Soldati, G Petrucci, E Rossi, A Timillero, ... Blood, The Journal of the American Society of Hematology 136 (2), 171-182, 2020 | 96 | 2020 |
| Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients O Marini, C Spina, E Mimiola, A Cassaro, G Malerba, G Todeschini, ... Oncotarget 7 (19), 27676, 2016 | 96 | 2016 |
| Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study T Barbui, A Ghirardi, A Masciulli, A Carobbio, F Palandri, N Vianelli, ... Leukemia 33 (8), 1996-2005, 2019 | 87 | 2019 |
| Social support, peer victimisation, and somatic complaints: A mediational analysis G Gini, G Carli, T Pozzoli Journal of paediatrics and child health 45 (6), 358-363, 2009 | 56 | 2009 |
| Beyond immune thrombocytopenia: the evolving role of thrombopoietin receptor agonists F Rodeghiero, G Carli Annals of Hematology 96 (9), 1421-1434, 2017 | 47 | 2017 |
| Second cancers in MPN: Survival analysis from an international study M Marchetti, A Ghirardi, A Masciulli, A Carobbio, F Palandri, N Vianelli, ... American journal of hematology 95 (3), 295-301, 2020 | 46 | 2020 |
| Real-world use of thrombopoietin receptor agonists in older patients with primary immune thrombocytopenia F Palandri, E Rossi, D Bartoletti, A Ferretti, M Ruggeri, E Lucchini, ... Blood, The Journal of the American Society of Hematology 138 (7), 571-583, 2021 | 44 | 2021 |
| Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients T Barbui, V De Stefano, A Carobbio, A Iurlo, A Alvarez-Larran, B Cuevas, ... Leukemia 35 (10), 2989-2993, 2021 | 43 | 2021 |
| Safety and efficacy of the maximum tolerated dose of givinostat in polycythemia vera: a two-part Phase Ib/II study A Rambaldi, A Iurlo, AM Vannucchi, R Noble, N Von Bubnoff, A Guarini, ... Leukemia 34 (8), 2234-2237, 2020 | 41 | 2020 |
| The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B2 assay as an … V De Stefano, B Rocca, A Tosetto, D Soldati, G Petrucci, E Beggiato, ... Blood Cancer Journal 8 (6), 49, 2018 | 40 | 2018 |
| Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study A Arcari, A Chiappella, M Spina, L Zanlari, P Bernuzzi, V Valenti, M Tani, ... Leukemia & lymphoma 57 (8), 1823-1830, 2016 | 40 | 2016 |
| Intensive short‐term chemotherapy regimen induces high remission rate (over 90%) and event‐free survival both in children and adult patients with advanced sporadic Burkitt … G Todeschini, M Bonifacio, C Tecchio, R Balter, G Carli, PM Stefani, ... American journal of hematology 87 (1), 22-25, 2012 | 40 | 2012 |
| Eltrombopag second‐line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off‐treatment: results of a phase II … E Lucchini, F Palandri, S Volpetti, N Vianelli, G Auteri, E Rossi, A Patriarca, ... British journal of haematology 193 (2), 386-396, 2021 | 38 | 2021 |
| Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19 T Barbui, V De Stefano, A Alvarez-Larran, A Iurlo, A Masciulli, A Carobbio, ... Blood cancer journal 11 (2), 21, 2021 | 38 | 2021 |
| Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms V De Stefano, A Carobbio, V Di Lazzaro, P Guglielmelli, A Iurlo, ... Blood cancer journal 8 (3), 25, 2018 | 36 | 2018 |
| A curriculum for training healthcare workers in the management of highly infectious diseases A Baka, FM Fusco, V Puro, N Vetter, P Skinhoj, K Ott, H Siikamäki, ... Eurosurveillance 12 (6), 5-6, 2007 | 35 | 2007 |
| Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival C Visco, E Falisi, KH Young, M Pascarella, O Perbellini, G Carli, E Novella, ... Oncotarget 6 (21), 18653, 2015 | 31 | 2015 |
